SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNAP -- Ignore unavailable to you. Want to Upgrade?

To: S. E. Baker who wrote (26)7/18/1998 5:20:00 PM
From: Biotech Jim  Read Replies (2) | Respond to of 124
 
If you count the odorant receptors, there are at least 1000 GPCRs. SNAP probably has patent protection on about 5 to 10, maybe more, and for several of these there are dual patents submitted. So, how many of these GPCRs are real targets, well no one really knows but is probably in the area of 100. Whether receptor sequence and "use" patents of this ilk will hold up in court remains to be tested.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News